Ovarian cancer
Results
Phase 2
This trial looked at adding nintedanib to cyclophosphamide for ovarian cancer that had come back.
It was open to women who had:
ovarian cancer
fallopian tube cancer
primary peritoneal cancer
Doctors treat these cancers in the same way. When we use the term ovarian cancer in this summary, we are referring to all 3.
This trial was open for women to join between 2014 and 2016. The team published the results in 2020.
Cancer Research UK supported this trial.
Recruitment start: 18 August 2014
Recruitment end: 12 December 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Marcia Hall
Boehringer Ingelheim
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University College London (UCL)
This is Cancer Research UK trial number CRUKE/11/024.
Last reviewed: 06 Sept 2021
CRUK internal database number: 8284
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
